Artrya Ltd
AYA
Company Profile
Business description
Artrya Ltd is a medical technology company. It is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. The company is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.
Contact
1257 Hay Street
West Perth
PerthWA6005
AUST: +61 864787816
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
30 June 2025
Employees
Stocks News & Analysis
stocks
Australian stocks will crush housing over the next decade, one year on
James Gruber looks back on his forecast for Australian equities and the housing market
stocks
10 best US blue-chip stocks to buy for the long term
The stocks of these high-quality companies with large market capitalisations look undervalued today.
stocks
What next for Tesla as 2024 deliveries disappoint?
Tesla shares started the year on a sour note. We think they continue to price in ambitious growth going forward.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,599.40 | 56.50 | 0.66% |
| CAC 40 | 7,490.07 | 0.72 | 0.01% |
| DAX 40 | 20,462.78 | 122.21 | 0.60% |
| Dow JONES (US) | 42,528.36 | 178.20 | -0.42% |
| FTSE 100 | 8,263.29 | 18.01 | 0.22% |
| HKSE | 19,279.84 | 167.74 | -0.86% |
| NASDAQ | 19,489.68 | 375.30 | -1.89% |
| Nikkei 225 | 39,981.06 | 102.24 | -0.26% |
| NZX 50 Index | 13,043.11 | 1.05 | 0.01% |
| S&P 500 | 5,909.03 | 66.35 | -1.11% |
| S&P/ASX 200 | 8,349.10 | 64.00 | 0.77% |
| SSE Composite Index | 3,230.17 | 0.52 | 0.02% |